Startup Atlas · Biotechnology
Vyome Therapeutics Listed
Dr. Shiladitya Sengupta · Co-Founder
Dr. Rajesh Gokhale · Co-Founder
Venkateswarlu Nelabhotla (N. Venkat) · Co-Founder & CEO
Rajiv Mantri · Co-Founder
$48.34 MnTotal funding (tracked)
5Funding rounds
3 Jan 2019Last round
Vyome Therapeutics: Funding Rounds
Disclosed round amounts over time, USD millions.
| Date | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 3 Jan 2019 | Series D | $22 Mn | Iron Pillar Kalaari Capital Perceptive Advisors Romulus Capital | source |
| 22 Aug 2016 | Series C | $14 Mn | Perceptive Advisors Romulus Capital Aarin Capital Kalaari Capital Sabre Partners | source |
| 12 Aug 2014 | Series B | $8 Mn | Sabre Partners Aarin Capital Kalaari Capital | source |
| 12 Sep 2012 | Series A | ₹18.5 Cr | IndoUS Venture Partners Aarin Capital Navam Capital | source |
| 2 Nov 2010 | Seed | $1 Mn | Navam Capital | source |
Vyome Therapeutics: Investors
Iron Pillar Kalaari Capital Perceptive Advisors Romulus Capital Aarin Capital Sabre Partners IndoUS Venture Partners Navam Capital
Acquisitions
| Date | Acquirer | Acquired | Amount | Source |
|---|---|---|---|---|
| 29 Sep 2025 | Vyome Therapeutics | Oculo, Inc. | Undisclosed | source |
FAQs on Vyome Therapeutics
How much funding has Vyome Therapeutics raised?
Vyome Therapeutics has raised $48.34 Mn across 5 tracked funding round(s), most recently on 2019-01-03. Figures are compiled from cited public sources.
Who are the investors in Vyome Therapeutics?
Investors in Vyome Therapeutics include Iron Pillar, Kalaari Capital, Perceptive Advisors, Romulus Capital, Aarin Capital, Sabre Partners.
Sources & corrections.
Every fact on this page is compiled from cited public sources — follow the "source" links beside each entry. Profile sources: www.biospace.com www.biopharmawatch.com · Last verified 24 Aug 2026. · Report a correction